Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


03.10.2017

1 APMIS
1 Asian Pac J Cancer Prev
1 BJU Int
1 BMJ Open
1 Bull Soc Pathol Exot
1 Cancer Biomark
1 Cancer Discov
1 Clin Oncol (R Coll Radiol)
1 Dtsch Med Wochenschr
1 Eur Urol
1 Food Funct
1 Hum Pathol
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Biochem
1 J Biomed Res
1 J Cancer Res Clin Oncol
1 J Hypertens
1 J Surg Oncol
1 J Vis Exp
1 Med Dosim
1 Med Sci Monit
2 Oncol Lett
3 Oncotarget
1 Radiother Oncol
1 Sci Rep
2 Urol Oncol
1 Urologiia
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    APMIS

  1. DEMATEI A, Fernandes R, Soares R, Alves H, et al
    Angiogenesis in Schistosoma haematobium-associated urinary bladder cancer.
    APMIS. 2017 Sep 28. doi: 10.1111/apm.12756.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  2. NASR R, Temraz S, Mukherji D, Shamseddine A, et al
    Distribution and Role of N-acetyltransferase 2 Genetic Polymorphisms in Bladder Cancer Risk in a Lebanese Population
    Asian Pac J Cancer Prev. 2017;18:2561-2568.
    PubMed     Text format     Abstract available


    BJU Int

  3. PICHLER R, Fritz J, Tulchiner G, Klinglmair G, et al
    Increased Accuracy of a novel mRNA-based Urine Test for Bladder Cancer Surveillance.
    BJU Int. 2017 Sep 20. doi: 10.1111/bju.14019.
    PubMed     Text format     Abstract available


    BMJ Open

  4. HAGGSTROM C, Liedberg F, Hagberg O, Aljabery F, et al
    Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe).
    BMJ Open. 2017;7:e016606.
    PubMed     Text format     Abstract available


    Bull Soc Pathol Exot

  5. BERRY A, Iriart X, Fillaux J, Magnaval JF, et al
    [Urinary schistosomiasis and cancer].
    Bull Soc Pathol Exot. 2017;110:68-75.
    PubMed     Text format     Abstract available


    Cancer Biomark

  6. WANG J, Ma W, Liu Y
    Long non-coding RNA HULC promotes bladder cancer cells proliferation but inhibits apoptosis via regulation of ZIC2 and PI3K/AKT signaling pathway.
    Cancer Biomark. 2017 Sep 15. doi: 10.3233/CBM-170188.
    PubMed     Text format     Abstract available


    Cancer Discov


  7. PPARG-Activated Bladder Cancer Cells Exhibit a PPARG Dependency.
    Cancer Discov. 2017 Sep 29. doi: 10.1158/2159-8290.CD-RW2017.
    PubMed     Text format     Abstract available


    Clin Oncol (R Coll Radiol)

  8. WALKER M, Doiron RC, French SD, Feldman-Stewart D, et al
    Bladder-sparing Radiotherapy for Muscle-invasive Bladder Cancer: A Qualitative Study to Identify Barriers and Enablers.
    Clin Oncol (R Coll Radiol). 2017 Sep 23. pii: S0936-6555(17)30396.
    PubMed     Text format     Abstract available


    Dtsch Med Wochenschr

  9. GEERDES-FENGE HF, Stubbe F, Lobermann M, Warnke P, et al
    [BCGitis with Involvement of Lung, Liver and Bone Marrow after Immunotherapy of Urothelial Cancer].
    Dtsch Med Wochenschr. 2017;142:1375-1378.
    PubMed     Text format     Abstract available


    Eur Urol

  10. BIRKENKAMP-DEMTRODER K, Christensen E, Nordentoft I, Knudsen M, et al
    Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis.
    Eur Urol. 2017 Sep 25. pii: S0302-2838(17)30775.
    PubMed     Text format     Abstract available


    Food Funct

  11. WU P, Liu S, Su J, Chen J, et al
    Apoptosis triggered by isoquercitrin in bladder cancer cells by activating the AMPK-activated protein kinase pathway.
    Food Funct. 2017 Sep 26. doi: 10.1039/c7fo00778.
    PubMed     Text format     Abstract available


    Hum Pathol

  12. ANNAN AC, Stevens KA, Osunkoya AO
    Urothelial carcinoma involving the ureteral orifice: a clinicopathologic analysis of 93 cases.
    Hum Pathol. 2017;65:101-106.
    PubMed     Text format     Abstract available


    Int J Cancer

  13. RAVA M, Czachorowski MJ, Silverman D, Marquez M, et al
    Asthma status is associated with decreased risk of aggressive urothelial bladder cancer.
    Int J Cancer. 2017 Sep 22. doi: 10.1002/ijc.31066.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  14. SOLANKI AA, Martin B, Korpics M, Small C, et al
    Bladder-Preserving Therapy Patterns of Care: A Survey of US Radiation Oncologists.
    Int J Radiat Oncol Biol Phys. 2017;99:383-387.
    PubMed     Text format     Abstract available


    J Biochem

  15. SUTOH YONEYAMA M, Tobisawa Y, Hatakeyama S, Sato M, et al
    A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I.
    J Biochem. 2017;161:479-492.
    PubMed     Text format     Abstract available


    J Biomed Res

  16. LIU Z, Ha US, Yu K, Wu C, et al
    Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway.
    J Biomed Res. 2017;31:408-418.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  17. ASAI A, Miyata Y, Takehara K, Kanda S, et al
    Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade.
    J Cancer Res Clin Oncol. 2017 Sep 26. doi: 10.1007/s00432-017-2524.
    PubMed     Text format     Abstract available


    J Hypertens

  18. CHUANG YW, Yu MC, Huang ST, Yang CK, et al
    Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case-control study.
    J Hypertens. 2017;35:170-177.
    PubMed     Text format     Abstract available


    J Surg Oncol

  19. PATKAR S, Ostwal V, Ramaswamy A, Engineer R, et al
    Emerging role of multimodality treatment in gall bladder cancer: Outcomes following 510 consecutive resections in a tertiary referral center.
    J Surg Oncol. 2017 Sep 20. doi: 10.1002/jso.24837.
    PubMed     Text format     Abstract available


    J Vis Exp

  20. THAM SM, Esuvaranathan K, Mahendran R
    A Murine Orthotopic Bladder Tumor Model and Tumor Detection System.
    J Vis Exp. 2017;.
    PubMed     Text format     Abstract available


    Med Dosim

  21. PASCIUTI K, Kuthpady S, Anderson A, Best B, et al
    Bladder radiotherapy treatment: A retrospective comparison of 3-dimensional conformal radiotherapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy plans.
    Med Dosim. 2017;42:1-6.
    PubMed     Text format     Abstract available


    Med Sci Monit

  22. ZHANG M, Ren B, Li Z, Niu W, et al
    Expression of N-Myc Downstream-Regulated Gene 2 in Bladder Cancer and Its Potential Utility as a Urinary Diagnostic Biomarker.
    Med Sci Monit. 2017;23:4644-4649.
    PubMed     Text format     Abstract available


    Oncol Lett

  23. CHANG Y, Xu J, Zhang Q
    Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer.
    Oncol Lett. 2017;14:4043-4052.
    PubMed     Text format     Abstract available

  24. SHEN L, Zhang F, Huang R, Yan J, et al
    Honokiol inhibits bladder cancer cell invasion through repressing SRC-3 expression and epithelial-mesenchymal transition.
    Oncol Lett. 2017;14:4294-4300.
    PubMed     Text format     Abstract available


    Oncotarget

  25. AVELLINI C, Licini C, Lazzarini R, Gesuita R, et al
    The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer.
    Oncotarget. 2017;8:58642-58653.
    PubMed     Text format     Abstract available

  26. ZHANG Z, Fan W, Deng Q, Tang S, et al
    The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies.
    Oncotarget. 2017;8:59527-59538.
    PubMed     Text format     Abstract available

  27. MA Y, Luo W, Bunch BL, Pratt RN, et al
    1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p.
    Oncotarget. 2017;8:60080-60093.
    PubMed     Text format     Abstract available


    Radiother Oncol

  28. WARSCHKOW R, Guller U, Cerny T, Schmied BM, et al
    Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis.
    Radiother Oncol. 2017;123:139-146.
    PubMed     Text format     Abstract available


    Sci Rep

  29. GHEIBI P, Zeng S, Son KJ, Vu T, et al
    Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells.
    Sci Rep. 2017;7:12277.
    PubMed     Text format     Abstract available


    Urol Oncol

  30. GOSNELL ME, Polikarpov DM, Goldys EM, Zvyagin AV, et al
    Computer-assisted cystoscopy diagnosis of bladder cancer.
    Urol Oncol. 2017 Sep 25. pii: S1078-1439(17)30460.
    PubMed     Text format     Abstract available

  31. RIEKEN M, Shariat SF, Kluth L, Crivelli JJ, et al
    Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer.
    Urol Oncol. 2017 Sep 22. pii: S1078-1439(17)30461.
    PubMed     Text format     Abstract available


    Urologiia

  32. KOMYAKOV BK, Sergeev AV, Fadeev VA, Ismailov KI, et al
    [Concomitant oncopathological changes in the prostate of urinary bladder cancer patients undergoing radical cystoprostateectomy].
    Urologiia. 2017;:42-45.
    PubMed     Text format     Abstract available


    Urology

  33. KISS B, Thoeny HC, Studer UE
    Current Status of Lymph Node Imaging in Bladder and Prostate Cancer.
    Urology. 2016 Mar 7. pii: S0090-4295(16)00182.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: